November 18, 2026
Health news, explained with evidence
LIVE

Study Evaluates Routine Blood Markers for Cardiovascular Comorbidities in Diabetes Patients

🏃 Fitness 1 min read 👁 3

A retrospective study examined whether standard blood-derived inflammatory and metabolic indices can effectively distinguish diabetes patients with documented cardiovascular comorbidities from those without.

🏃Fitness

Key points

  • Retrospective analysis evaluated 7,034 diabetes patients with and without cardiovascular comorbidities
  • Assessed routine blood-derived metabolic and inflammatory indices, such as the TyG index and cell ratios
  • Machine-learning models showed poor to modest ability to distinguish the clinical groups at the individual level

Researchers at the George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Târgu Mureș evaluated data from 7,034 patients to see if routine laboratory variables could differentiate individuals diagnosed with diabetes alone from those who also had documented cardiovascular complications. The retrospective exploratory analysis looked at various indices, including the triglyceride/glucose index, monocyte-to-HDL ratio, systemic inflammation response index, and several cell ratios.

While statistical comparisons identified several significant differences between the two patient groups, the vast majority of these effect sizes proved to be negligible or small, highlighting substantial overlap in laboratory values. Machine-learning classification models demonstrated poor to modest discriminatory capability, indicating that these routine markers lack sufficient stand-alone utility for individual-level clinical diagnosis. The authors emphasize that the research was observational and exploratory, relying on retrospective data that call for future prospective validation using longitudinal outcomes and complete medication details.

What to know: Standard blood tests provide helpful population-level insights into metabolic and inflammatory patterns, but they currently show limited value for singling out individual cardiovascular risks in diabetes patients. Always consult a qualified healthcare provider for personalized medical decisions and risk assessments.

Source Nature Health Sciences — nature.com/articles/s41598-026-79096-8 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.